$1.72
2.56% yesterday
Nasdaq, Jun 12, 10:00 pm CET
ISIN
US03837C1062
Symbol
APYX

Apyx Medical Corporation Stock price

$1.72
+0.61 55.20% 1M
+0.03 1.48% 6M
+0.14 8.54% YTD
+0.16 10.64% 1Y
-3.16 64.78% 5Y
-0.95 35.53% 10Y
-0.54 23.78% 20Y
Nasdaq, Closing price Thu, Jun 12 2025
-0.05 2.56%
ISIN
US03837C1062
Symbol
APYX
Sector

Key metrics

Market capitalization $64.82m
Enterprise Value $67.98m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 1.44
P/S ratio (TTM) P/S ratio 1.37
P/B ratio (TTM) P/B ratio 6.17
Revenue growth (TTM) Revenue growth -6.28%
Revenue (TTM) Revenue $47.29m
EBIT (operating result TTM) EBIT $-15.28m
Free Cash Flow (TTM) Free Cash Flow $-13.15m
Cash position $31.01m
EPS (TTM) EPS $-0.49
P/E forward negative
P/S forward 1.34
EV/Sales forward 1.41
Short interest 0.85%
Show more

Is Apyx Medical Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,845 stocks worldwide.

Apyx Medical Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

3 Analysts have issued a Apyx Medical Corporation forecast:

1x Buy
33%
2x Hold
67%

Analyst Opinions

3 Analysts have issued a Apyx Medical Corporation forecast:

Buy
33%
Hold
67%

Financial data from Apyx Medical Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
47 47
6% 6%
100%
- Direct Costs 18 18
1% 1%
39%
29 29
10% 10%
61%
- Selling and Administrative Expenses 40 40
17% 17%
84%
- Research and Development Expense 4.49 4.49
12% 12%
9%
-15 -15
29% 29%
-31%
- Depreciation and Amortization 0.58 0.58
11% 11%
1%
EBIT (Operating Income) EBIT -15 -15
28% 28%
-32%
Net Profit -20 -20
12% 12%
-42%

In millions USD.

Don't miss a Thing! We will send you all news about Apyx Medical Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Apyx Medical Corporation Stock News

Neutral
PRNewsWire
14 days ago
Highlighting Real Patient Journeys and Empowering Confidence Through Loose Skin Solutions and Body Contouring CLEARWATER, Fla. , May 30, 2025 /PRNewswire/ -- Apyx® Medical Corporation (NASDAQ: APYX) ("Apyx Medical" or the "Company"), the manufacturer of the proprietary helium plasma and radiofrequency platform technology marketed and sold as Renuvion®, is once again taking center stage—this tim...
Neutral
GlobeNewsWire
about one month ago
The AYON Body Contouring System is the first FDA cleared all-in-one platform for the aesthetic surgical suite Plan to initiate the commercial launch of the AYON Body Contouring System to key opinion leader surgeons in critical geographies during the second half of 2025 CLEARWATER, Fla., May 13, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical”; the “Company”), the ...
Neutral
Seeking Alpha
about one month ago
Apyx Medical Corporation (NASDAQ:APYX ) Q1 2025 Earnings Conference Call May 8, 2025 8:00 AM ET Company Participants Jeremy Feffer – LifeSci Advisors Charlie Goodwin – Chief Executive Officer Matt Hill – Chief Financial Officer Conference Call Participants Matt Hewitt – Craig-Hallum Capital Group Sam Eiber – BTIG Operator Ladies and gentlemen, good morning, and welcome to the Apyx Medical First...
More Apyx Medical Corporation News

Company Profile

Apyx Medical Corp. operates as an energy-based medical technology company. The firm engages in developing, manufacturing, and marketing a range of electrosurgical products and technologies, as well as related medical products used the offices of doctors, surgery centers, and hospitals worldwide. It operates through the following segments: Advanced Energy and Original Equipment Manufacture (OME). The company was founded by Andrew Makrides in 1978 and is headquartered in Clearwater, FL.

Head office United States
CEO Charles Goodwin
Employees 220
Founded 1978
Website apyxmedical.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today